Purple urine bag syndrome in a hemodialysis patient

Internal Medicine

Volumn 44, Issue 8, 2005, Pages 859-861

  Wang, I Kuan ^a   Ho, Dong Ru ^a   Chang, Hung Yu ^a   Lin, Chun Liang ^a   Chuang, Feng Rong ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Hemodialysis; Purple urine bag sundrome; Urinary tract infection

Indexed keywords

CEFUROXIME; INDICAN; INDIRUBIN; INDOXYL SULFATASE; SULFATASE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; BALLOON CATHETER; BLADDER CATHETERIZATION; CASE REPORT; CATHETER INFECTION; CONSTIPATION; DIABETIC NEPHROPATHY; DISEASE COURSE; DISPOSABLE EQUIPMENT; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMOBILIZATION; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE; MAINTENANCE THERAPY; PROTEUS VULGARIS; PURPLE URINE BAG SYNDROME; SEPSIS; SEX DIFFERENCE; TRYPTOPHAN METABOLISM; URINE COLOR; URINE CULTURE;

BACTERIA; COLOR; DIABETIC NEPHROPATHIES; FEMALE; FERMENTATION; HUMANS; INDICAN; INDOLES; MIDDLE AGED; PLASTICS; RENAL DIALYSIS; URINARY CATHETERIZATION;

EID: 24644501273     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.859     Document Type: Article

References (16)

1. Barlow GB, Dickson JAS. Purple urine bags. Lancet 1: 220-221, 1978.
2. Sammons HG, Skinner C, Fields J. Purple urine bags. Lancet 1: 502, 1978.
3. Payne B, Grant A. Purple urine bags. Lancet 1: 502, 1978.
4. Dealler SF, Belfield PW, Bedford M, Whitley AJ, Mulley GP. Purple urine bags. J Urol 142: 769-770, 1989.
5. Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1497 catheterized patients. Arch Intern Med 160: 678-682, 2000.
6. Dealler SF, Hawkey PM, Millar MR. Enzymatic degradation of urinary indoxyl sulfate by Providencia stuartii and Klebsiella pneumoniae causes the purple urine bag syndrome. J Clin Microbiol 26: 2152-2156, 1988.
7. Sapira JD, Somani S, Shapiro AP, Scheib ET. Reihl W. Some observations concerning mammalian indoxyl metabolism and its relationship to the formation of urinary indigo pigments. Metabolism 20: 474-486, 1971.
8. Nakayama T, Kanmatsuse K. Serum levels of amino acid in patients with purple urine bag syndrome. Nippon Jinzo Gakkai Shi 39: 470-473, 1997 (in Japanese).
9. Matsuo H, Ishibashi T, Araki C, et al. Report of three cases of purple urine bag syndrome which occurred with a combination of both E. coli and M. morganii. Kansenshogaku Zasshi 67: 487-490, 1993 (in Japanese).
10. Ishida T, Ogura S, Kawakami Y. Five cases of purple urine bag syndrome in a geriatric ward. Nippon Ronen Igakkai Zasshi 36: 826-829, 1999 (in Japanese).
11. Al-Jubouri MA, Vardhan MS. A case of purple urine bag syndrome associated with Providencia rettgeri. J Clin Pathol 54: 412-416, 2001.
12. Nobukuni K, Kawahara S, Nagare H, Fujita Y. Study on purple pigmentation in five cases with purple urine bag syndrome. Kansenshogaku Zasshi 69: 1269-1271, 1995 (in Japanese).
13. Niwa T, Takeda N, Tatematsu A, Maeda K. Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin Chem 34: 2264-2267, 1989.
14. Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh N, Koga Y. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 74: 349-355, 1996.
15. Brunet P, Dou L, Cerini C, Berland Y. Protein-bound uremic retention solutes. Adv Ren Replace Ther 10: 310-320, 2003.
16. Niwa T, Tsukushi S, Ise M, et al. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Miner Electrolyte Metab 23: 179-184, 1997.